Nebivolol suppresses glioblastoma progression via dual modulation of mitochondrial metabolism and AKT/mTOR/4EBP1 signaling axis

Glioblastoma (GBM) is the most malignant and aggressive form of brain tumor, characterized by limited therapeutic options and poor prognosis. Despite continuous advances in ongoing research, effective therapeutic strategies remain scarce. In th...